se of surfactant with corticosteroids to prevent chronic lung disease in premature infants

Not Applicable

Recruiting

• Conditions: Bronchopulmonary dysplasia originating in the perinatal period; P27.1

• Registration Number: RBR-72kkgc
• Lead Sponsor: Hospital das Clínicas da Universidade Federal de Goiás

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-06-23
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Every newborn with 0-2 hours of life; both sexes; who required prophylactic surfactant or early redemption replacement therapy. Sample size target: 90 research subjects.

Exclusion Criteria

Loss of follow-up of the newborn before 28 days of chronological age (except in case of death);
Congenital malformations of heart and lung; except patent ductus arteriosus and pervious foramen ovale.

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement in respiratory status increase survival rate and/or decrease bronchopulmonary dysplasia<br><br>

Secondary Outcome Measures

Name	Time	Method
Early intratracheal instillation of a budesonide-surfactant mixture improve the respiratory status in preterm infants with moderate to severe respiratory distress syndrome